Skip to content
AnalystLens

CME GROUP INC. 8-K Report, Executive Changes (Feb 28, 2023)

Reports
Leadership Changes·Exhibits & Filings
Filing Date
Filed February 28, 2023
Period End
February 23, 2023
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Feb ’20Feb ’20
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed February 28, 2023. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. (CME) announced a key leadership transition in its finance department via an 8-K filing.

Effective April 1, 2023, Lynne Fitzpatrick will assume the role of Chief Financial Officer, succeeding John W. Pietrowicz, who is retiring from the CFO position but will remain with the company as a Special Advisor until December 31, 2023. This transition represents a planned succession, with Ms. Fitzpatrick's extensive experience within CME Group's finance organization, including her recent role as Senior Managing Director & Deputy Chief Financial Officer, positioning her well for the CFO responsibilities.

Ms. Fitzpatrick's tenure at CME Group dates back to 2006, and she has held various leadership positions, notably leading business development, M&A, CME Ventures, and corporate treasury. Her appointment to CFO is expected to maintain continuity in financial strategy and operations. The filing also confirms no immediate concerns regarding family relationships or related-party transactions involving Ms. Fitzpatrick.

Key Highlights

  1. Lynne Fitzpatrick appointed Chief Financial Officer (CFO) effective April 1, 2023.
  2. Current CFO John W. Pietrowicz to retire from CFO role but will serve as Special Advisor until December 31, 2023.
  3. The CFO transition is a planned succession.
  4. Fitzpatrick has extensive experience within CME Group, holding roles including Senior Managing Director & Deputy CFO, and leading Corporate Development and Treasurer functions.
  5. Fitzpatrick's compensation as CFO will be commensurate with other executive officers at the Senior Managing Director level.
  6. No family relationships exist between Ms. Fitzpatrick and any executive officer or director of CME Group.
  7. No related-party transactions involving Ms. Fitzpatrick or her immediate family are disclosed.

Frequently Asked Questions

  1. Who is the new Chief Financial Officer of CME Group?

    Lynne Fitzpatrick has been appointed as the new Chief Financial Officer of CME Group, effective April 1, 2023.

  2. What is happening with the current CFO, John W. Pietrowicz?

    John W. Pietrowicz is retiring from his position as Chief Financial Officer on April 1, 2023. He will remain with CME Group as a Special Advisor until December 31, 2023, to ensure a smooth transition.

  3. What is Lynne Fitzpatrick's background and experience at CME Group?

    Lynne Fitzpatrick has a long history with CME Group, joining in 2006. She most recently served as Senior Managing Director & Deputy Chief Financial Officer since February 2022. Prior to that, she was Managing Director of Corporate Development and Treasurer, overseeing business development, M&A, CME Ventures, and corporate treasury. She has held various other positions within the finance organization during her tenure.

  4. Are there any potential conflicts of interest with the new CFO?

    The filing states that there are no family relationships between Ms. Fitzpatrick and any executive officer or director of CME Group. Additionally, there are no disclosed related-party transactions in which Ms. Fitzpatrick or her immediate family were or will be participants.